Industry Research Reports
Home > Reports > Service & Software > Postbiotics CDMO Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Postbiotics CDMO Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Service & Software
Published Date: 2025-03-12
Pages: 89 Pages
Report ld: 4650121
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Postbiotics CDMO Service Market Size(US$)
CAGR 2025-2031
9.3%
Market Size,2031
USD 182
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 107 million
Market Forecast in 2031(Value)
US$ 182 million
CAGR
9.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Postbiotics CDMO Service was estimated to be worth US$ 99 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Postbiotics are inactivated microorganisms and/or bacterial components with a clear genetic background that are beneficial to the health of the host, including or excluding products of their metabolites; chemically synthesized components and viruses/bacteriophages and their products are excluded. Postbiotic products are added with postbiotic ingredients and are widely used in different fields (feed, food health, personal care, pet nutrition, etc.).CDMOs (Contract Development and Manufacturing Organizations) provide professional R&D and production services to other companies to help them bring postbiotic products to market. These organizations usually have extensive R&D experience and production capabilities to meet the needs of different customers.
North American market for Postbiotics CDMO Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Postbiotics CDMO Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Postbiotics CDMO Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Postbiotics CDMO Service include ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Exden, JuneYao Group (BioGrowing), dsm-firmenich (Adare Pharma Solutions), Sirio Pharma, Sacco System, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Postbiotics CDMO Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Postbiotics CDMO Service by region & country, by Type, and by Application.
The Postbiotics CDMO Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Postbiotics CDMO Service.
MARKET SEGMENTATION
By Company
- ILDONG Bioscience Co., Ltd.
- Bioprox Healthcare
- Exden
- JuneYao Group (BioGrowing)
- dsm-firmenich (Adare Pharma Solutions)
- Sirio Pharma
- Sacco System
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Oral Dosage Forms (Capsules And Tablets)
- Powders and Granules
- Liquid Preparations
Segment by Application
- Medicines and Health Products
- Food
- Pet Food
- Cosmetics
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Postbiotics CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Postbiotics CDMO Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Postbiotics CDMO Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Postbiotics CDMO Service Product Introduction
1.2 Global Postbiotics CDMO Service Market Size Forecast (2020-2031)
1.3 Postbiotics CDMO Service Market Trends & Drivers
1.3.1 Postbiotics CDMO Service Industry Trends
1.3.2 Postbiotics CDMO Service Market Drivers & Opportunity
1.3.3 Postbiotics CDMO Service Market Challenges
1.3.4 Postbiotics CDMO Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Postbiotics CDMO Service Players Revenue Ranking (2024)
2.2 Global Postbiotics CDMO Service Revenue by Company (2020-2025)
2.3 Key Companies Postbiotics CDMO Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Postbiotics CDMO Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Postbiotics CDMO Service
2.6 Postbiotics CDMO Service Market Competitive Analysis
2.6.1 Postbiotics CDMO Service Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Postbiotics CDMO Service Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postbiotics CDMO Service as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral Dosage Forms (Capsules And Tablets)
3.1.2 Powders and Granules
3.1.3 Liquid Preparations
3.2 Global Postbiotics CDMO Service Sales Value by Type
3.2.1 Global Postbiotics CDMO Service Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Postbiotics CDMO Service Sales Value, by Type (2020-2031)
3.2.3 Global Postbiotics CDMO Service Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medicines and Health Products
4.1.2 Food
4.1.3 Pet Food
4.1.4 Cosmetics
4.2 Global Postbiotics CDMO Service Sales Value by Application
4.2.1 Global Postbiotics CDMO Service Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Postbiotics CDMO Service Sales Value, by Application (2020-2031)
4.2.3 Global Postbiotics CDMO Service Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Postbiotics CDMO Service Sales Value by Region
5.1.1 Global Postbiotics CDMO Service Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Postbiotics CDMO Service Sales Value by Region (2020-2025)
5.1.3 Global Postbiotics CDMO Service Sales Value by Region (2026-2031)
5.1.4 Global Postbiotics CDMO Service Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Postbiotics CDMO Service Sales Value, 2020-2031
5.2.2 North America Postbiotics CDMO Service Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Postbiotics CDMO Service Sales Value, 2020-2031
5.3.2 Europe Postbiotics CDMO Service Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Postbiotics CDMO Service Sales Value, 2020-2031
5.4.2 Asia Pacific Postbiotics CDMO Service Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Postbiotics CDMO Service Sales Value, 2020-2031
5.5.2 South America Postbiotics CDMO Service Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Postbiotics CDMO Service Sales Value, 2020-2031
5.6.2 Middle East & Africa Postbiotics CDMO Service Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Postbiotics CDMO Service Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Postbiotics CDMO Service Sales Value, 2020-2031
6.3 United States
6.3.1 United States Postbiotics CDMO Service Sales Value, 2020-2031
6.3.2 United States Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Postbiotics CDMO Service Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Postbiotics CDMO Service Sales Value, 2020-2031
6.4.2 Europe Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Postbiotics CDMO Service Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Postbiotics CDMO Service Sales Value, 2020-2031
6.5.2 China Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
6.5.3 China Postbiotics CDMO Service Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Postbiotics CDMO Service Sales Value, 2020-2031
6.6.2 Japan Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Postbiotics CDMO Service Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Postbiotics CDMO Service Sales Value, 2020-2031
6.7.2 South Korea Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Postbiotics CDMO Service Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Postbiotics CDMO Service Sales Value, 2020-2031
6.8.2 Southeast Asia Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Postbiotics CDMO Service Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Postbiotics CDMO Service Sales Value, 2020-2031
6.9.2 India Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
6.9.3 India Postbiotics CDMO Service Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 ILDONG Bioscience Co., Ltd.
7.1.1 ILDONG Bioscience Co., Ltd. Profile
7.1.2 ILDONG Bioscience Co., Ltd. Main Business
7.1.3 ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Products, Services and Solutions
7.1.4 ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Revenue (US$ Million) & (2020-2025)
7.1.5 ILDONG Bioscience Co., Ltd. Recent Developments
7.2 Bioprox Healthcare
7.2.1 Bioprox Healthcare Profile
7.2.2 Bioprox Healthcare Main Business
7.2.3 Bioprox Healthcare Postbiotics CDMO Service Products, Services and Solutions
7.2.4 Bioprox Healthcare Postbiotics CDMO Service Revenue (US$ Million) & (2020-2025)
7.2.5 Bioprox Healthcare Recent Developments
7.3 Exden
7.3.1 Exden Profile
7.3.2 Exden Main Business
7.3.3 Exden Postbiotics CDMO Service Products, Services and Solutions
7.3.4 Exden Postbiotics CDMO Service Revenue (US$ Million) & (2020-2025)
7.3.5 Exden Recent Developments
7.4 JuneYao Group (BioGrowing)
7.4.1 JuneYao Group (BioGrowing) Profile
7.4.2 JuneYao Group (BioGrowing) Main Business
7.4.3 JuneYao Group (BioGrowing) Postbiotics CDMO Service Products, Services and Solutions
7.4.4 JuneYao Group (BioGrowing) Postbiotics CDMO Service Revenue (US$ Million) & (2020-2025)
7.4.5 JuneYao Group (BioGrowing) Recent Developments
7.5 dsm-firmenich (Adare Pharma Solutions)
7.5.1 dsm-firmenich (Adare Pharma Solutions) Profile
7.5.2 dsm-firmenich (Adare Pharma Solutions) Main Business
7.5.3 dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Products, Services and Solutions
7.5.4 dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Revenue (US$ Million) & (2020-2025)
7.5.5 dsm-firmenich (Adare Pharma Solutions) Recent Developments
7.6 Sirio Pharma
7.6.1 Sirio Pharma Profile
7.6.2 Sirio Pharma Main Business
7.6.3 Sirio Pharma Postbiotics CDMO Service Products, Services and Solutions
7.6.4 Sirio Pharma Postbiotics CDMO Service Revenue (US$ Million) & (2020-2025)
7.6.5 Sirio Pharma Recent Developments
7.7 Sacco System
7.7.1 Sacco System Profile
7.7.2 Sacco System Main Business
7.7.3 Sacco System Postbiotics CDMO Service Products, Services and Solutions
7.7.4 Sacco System Postbiotics CDMO Service Revenue (US$ Million) & (2020-2025)
7.7.5 Sacco System Recent Developments
8 Industry Chain Analysis
8.1 Postbiotics CDMO Service Industrial Chain
8.2 Postbiotics CDMO Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Postbiotics CDMO Service Sales Model
8.5.2 Sales Channel
8.5.3 Postbiotics CDMO Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Postbiotics CDMO Service Market Trends
Table 2. Postbiotics CDMO Service Market Drivers & Opportunity
Table 3. Postbiotics CDMO Service Market Challenges
Table 4. Postbiotics CDMO Service Market Restraints
Table 5. Global Postbiotics CDMO Service Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Postbiotics CDMO Service Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Postbiotics CDMO Service Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Postbiotics CDMO Service Product Type
Table 9. Key Companies Time to Begin Mass Production of Postbiotics CDMO Service
Table 10. Global Postbiotics CDMO Service Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postbiotics CDMO Service as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Postbiotics CDMO Service Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Postbiotics CDMO Service Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Postbiotics CDMO Service Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Postbiotics CDMO Service Sales Market Share in Value by Type (2020-2025)
Table 17. Global Postbiotics CDMO Service Sales Market Share in Value by Type (2026-2031)
Table 18. Global Postbiotics CDMO Service Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Postbiotics CDMO Service Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Postbiotics CDMO Service Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Postbiotics CDMO Service Sales Market Share in Value by Application (2020-2025)
Table 22. Global Postbiotics CDMO Service Sales Market Share in Value by Application (2026-2031)
Table 23. Global Postbiotics CDMO Service Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Postbiotics CDMO Service Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Postbiotics CDMO Service Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Postbiotics CDMO Service Sales Value by Region (2020-2025) & (%)
Table 27. Global Postbiotics CDMO Service Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Postbiotics CDMO Service Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Postbiotics CDMO Service Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Postbiotics CDMO Service Sales Value, (2026-2031) & (US$ Million)
Table 31. ILDONG Bioscience Co., Ltd. Basic Information List
Table 32. ILDONG Bioscience Co., Ltd. Description and Business Overview
Table 33. ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Products, Services and Solutions
Table 34. Revenue (US$ Million) in Postbiotics CDMO Service Business of ILDONG Bioscience Co., Ltd. (2020-2025)
Table 35. ILDONG Bioscience Co., Ltd. Recent Developments
Table 36. Bioprox Healthcare Basic Information List
Table 37. Bioprox Healthcare Description and Business Overview
Table 38. Bioprox Healthcare Postbiotics CDMO Service Products, Services and Solutions
Table 39. Revenue (US$ Million) in Postbiotics CDMO Service Business of Bioprox Healthcare (2020-2025)
Table 40. Bioprox Healthcare Recent Developments
Table 41. Exden Basic Information List
Table 42. Exden Description and Business Overview
Table 43. Exden Postbiotics CDMO Service Products, Services and Solutions
Table 44. Revenue (US$ Million) in Postbiotics CDMO Service Business of Exden (2020-2025)
Table 45. Exden Recent Developments
Table 46. JuneYao Group (BioGrowing) Basic Information List
Table 47. JuneYao Group (BioGrowing) Description and Business Overview
Table 48. JuneYao Group (BioGrowing) Postbiotics CDMO Service Products, Services and Solutions
Table 49. Revenue (US$ Million) in Postbiotics CDMO Service Business of JuneYao Group (BioGrowing) (2020-2025)
Table 50. JuneYao Group (BioGrowing) Recent Developments
Table 51. dsm-firmenich (Adare Pharma Solutions) Basic Information List
Table 52. dsm-firmenich (Adare Pharma Solutions) Description and Business Overview
Table 53. dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Products, Services and Solutions
Table 54. Revenue (US$ Million) in Postbiotics CDMO Service Business of dsm-firmenich (Adare Pharma Solutions) (2020-2025)
Table 55. dsm-firmenich (Adare Pharma Solutions) Recent Developments
Table 56. Sirio Pharma Basic Information List
Table 57. Sirio Pharma Description and Business Overview
Table 58. Sirio Pharma Postbiotics CDMO Service Products, Services and Solutions
Table 59. Revenue (US$ Million) in Postbiotics CDMO Service Business of Sirio Pharma (2020-2025)
Table 60. Sirio Pharma Recent Developments
Table 61. Sacco System Basic Information List
Table 62. Sacco System Description and Business Overview
Table 63. Sacco System Postbiotics CDMO Service Products, Services and Solutions
Table 64. Revenue (US$ Million) in Postbiotics CDMO Service Business of Sacco System (2020-2025)
Table 65. Sacco System Recent Developments
Table 66. Key Raw Materials Lists
Table 67. Raw Materials Key Suppliers Lists
Table 68. Postbiotics CDMO Service Downstream Customers
Table 69. Postbiotics CDMO Service Distributors List
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Postbiotics CDMO Service Product Picture
Figure 2. Global Postbiotics CDMO Service Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Postbiotics CDMO Service Sales Value (2020-2031) & (US$ Million)
Figure 4. Postbiotics CDMO Service Report Years Considered
Figure 5. Global Postbiotics CDMO Service Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Postbiotics CDMO Service Revenue in 2024
Figure 7. Postbiotics CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Oral Dosage Forms (Capsules And Tablets) Picture
Figure 9. Powders and Granules Picture
Figure 10. Liquid Preparations Picture
Figure 11. Global Postbiotics CDMO Service Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Postbiotics CDMO Service Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Medicines and Health Products
Figure 14. Product Picture of Food
Figure 15. Product Picture of Pet Food
Figure 16. Product Picture of Cosmetics
Figure 17. Global Postbiotics CDMO Service Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 18. Global Postbiotics CDMO Service Sales Value Market Share by Application, 2024 & 2031
Figure 19. North America Postbiotics CDMO Service Sales Value (2020-2031) & (US$ Million)
Figure 20. North America Postbiotics CDMO Service Sales Value by Country (%), 2024 VS 2031
Figure 21. Europe Postbiotics CDMO Service Sales Value, (2020-2031) & (US$ Million)
Figure 22. Europe Postbiotics CDMO Service Sales Value by Country (%), 2024 VS 2031
Figure 23. Asia Pacific Postbiotics CDMO Service Sales Value, (2020-2031) & (US$ Million)
Figure 24. Asia Pacific Postbiotics CDMO Service Sales Value by Region (%), 2024 VS 2031
Figure 25. South America Postbiotics CDMO Service Sales Value, (2020-2031) & (US$ Million)
Figure 26. South America Postbiotics CDMO Service Sales Value by Country (%), 2024 VS 2031
Figure 27. Middle East & Africa Postbiotics CDMO Service Sales Value, (2020-2031) & (US$ Million)
Figure 28. Middle East & Africa Postbiotics CDMO Service Sales Value by Country (%), 2024 VS 2031
Figure 29. Key Countries/Regions Postbiotics CDMO Service Sales Value (%), (2020-2031)
Figure 30. United States Postbiotics CDMO Service Sales Value, (2020-2031) & (US$ Million)
Figure 31. United States Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
Figure 32. United States Postbiotics CDMO Service Sales Value by Application (%), 2024 VS 2031
Figure 33. Europe Postbiotics CDMO Service Sales Value, (2020-2031) & (US$ Million)
Figure 34. Europe Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
Figure 35. Europe Postbiotics CDMO Service Sales Value by Application (%), 2024 VS 2031
Figure 36. China Postbiotics CDMO Service Sales Value, (2020-2031) & (US$ Million)
Figure 37. China Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
Figure 38. China Postbiotics CDMO Service Sales Value by Application (%), 2024 VS 2031
Figure 39. Japan Postbiotics CDMO Service Sales Value, (2020-2031) & (US$ Million)
Figure 40. Japan Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
Figure 41. Japan Postbiotics CDMO Service Sales Value by Application (%), 2024 VS 2031
Figure 42. South Korea Postbiotics CDMO Service Sales Value, (2020-2031) & (US$ Million)
Figure 43. South Korea Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
Figure 44. South Korea Postbiotics CDMO Service Sales Value by Application (%), 2024 VS 2031
Figure 45. Southeast Asia Postbiotics CDMO Service Sales Value, (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
Figure 47. Southeast Asia Postbiotics CDMO Service Sales Value by Application (%), 2024 VS 2031
Figure 48. India Postbiotics CDMO Service Sales Value, (2020-2031) & (US$ Million)
Figure 49. India Postbiotics CDMO Service Sales Value by Type (%), 2024 VS 2031
Figure 50. India Postbiotics CDMO Service Sales Value by Application (%), 2024 VS 2031
Figure 51. Postbiotics CDMO Service Industrial Chain
Figure 52. Postbiotics CDMO Service Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Postbiotics CDMO Service market size from 2025 to 2031?
The annual compound growth rate of the global Postbiotics CDMO Service market is 9.3% 2025 to 2031.
Which region is expected to have the highest market share?
What was the global market size of Postbiotics CDMO Service in 2031?
Which companies rank high in the global Postbiotics CDMO Service market?
What was the global market size of Postbiotics CDMO Service in 2025?
Related Reports
Global Postbiotics CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Postbiotics CDMO Service market is projected to grow from US$ 107 million in 2025 to US$ 198 million by 2032, at a CAGR of 9.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-25
Pages: 118
USD 4900.00
(Single User License)
Global Postbiotics CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Postbiotics CDMO Service market size was US$ 107 million in 2025 and is forecast to reach a readjusted size of US$ 198 million by 2032 with a CAGR of 9.3% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 76
USD 4250.00
(Single User License)
Global Postbiotics CDMO Service Market Research Report 2026
The global Postbiotics CDMO Service market was valued at US$ 107 million in 2025 and is anticipated to reach US$ 198 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 110
USD 2900.00
(Single User License)
Postbiotics CDMO Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Postbiotics CDMO Service was estimated to be worth US$ 107 million in 2025 and is projected to reach US$ 198 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 94
USD 3950.00
(Single User License)
Global Postbiotics CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Postbiotics CDMO Service market size was US$ 99 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 79
USD 4250.00
(Single User License)
Global Postbiotics CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Postbiotics CDMO Service market is projected to grow from US$ 99 million in 2024 to US$ 182 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-01
Pages: 123
USD 4900.00
(Single User License)
Global Postbiotics CDMO Service Market Research Report 2025
The global market for Postbiotics CDMO Service was valued at US$ 99 million in the year 2024 and is projected to reach a revised size of US$ 182 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published Date: 2025-03-12
Pages: 77
USD 2900.00
(Single User License)
Global Postbiotics CDMO Service Market Insights, Forecast to 2030
The global Postbiotics CDMO Service market is projected to grow from US$ 99 million in 2024 to US$ 168 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period.
Published Date: 2024-11-15
Pages: 130
USD 4900.00
(Single User License)
Global and United States Postbiotics CDMO Service Market Report & Forecast 2024-2030
The global Postbiotics CDMO Service revenue was US$ 88.7 million in 2023 and is forecast to a readjusted size of US$ 168 million by 2030 with a CAGR of 9.3% during the review period (2024-2030).
Published Date: 2024-11-15
Pages: 98
USD 4350.00
(Single User License)
Postbiotics CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Postbiotics CDMO Service was estimated to be worth US$ 88.7 million in 2023 and is forecast to a readjusted size of US$ 168 million by 2030 with a CAGR of 9.3% during the forecast period 2024-2030.
Published Date: 2024-11-15
Pages: 99
USD 3950.00
(Single User License)
Global Postbiotics CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Postbiotics CDMO Service market is projected to grow from US$ 107 million in 2025 to US$ 198 million by 2032, at a CAGR of 9.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-25
Pages: 118
USD 4900.00 (Single User License)Global Postbiotics CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Postbiotics CDMO Service market size was US$ 107 million in 2025 and is forecast to reach a readjusted size of US$ 198 million by 2032 with a CAGR of 9.3% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 76
USD 4250.00 (Single User License)Global Postbiotics CDMO Service Market Research Report 2026
The global Postbiotics CDMO Service market was valued at US$ 107 million in 2025 and is anticipated to reach US$ 198 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 110
USD 2900.00 (Single User License)Postbiotics CDMO Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Postbiotics CDMO Service was estimated to be worth US$ 107 million in 2025 and is projected to reach US$ 198 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 94
USD 3950.00 (Single User License)Global Postbiotics CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Postbiotics CDMO Service market size was US$ 99 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 79
USD 4250.00 (Single User License)Global Postbiotics CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Postbiotics CDMO Service market is projected to grow from US$ 99 million in 2024 to US$ 182 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-01
Pages: 123
USD 4900.00 (Single User License)Global Postbiotics CDMO Service Market Research Report 2025
The global market for Postbiotics CDMO Service was valued at US$ 99 million in the year 2024 and is projected to reach a revised size of US$ 182 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published: 2025-03-12
Pages: 77
USD 2900.00 (Single User License)Global Postbiotics CDMO Service Market Insights, Forecast to 2030
The global Postbiotics CDMO Service market is projected to grow from US$ 99 million in 2024 to US$ 168 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period.
Published: 2024-11-15
Pages: 130
USD 4900.00 (Single User License)Global and United States Postbiotics CDMO Service Market Report & Forecast 2024-2030
The global Postbiotics CDMO Service revenue was US$ 88.7 million in 2023 and is forecast to a readjusted size of US$ 168 million by 2030 with a CAGR of 9.3% during the review period (2024-2030).
Published: 2024-11-15
Pages: 98
USD 4350.00 (Single User License)Postbiotics CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Postbiotics CDMO Service was estimated to be worth US$ 88.7 million in 2023 and is forecast to a readjusted size of US$ 168 million by 2030 with a CAGR of 9.3% during the forecast period 2024-2030.
Published: 2024-11-15
Pages: 99
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now